HealthEquity, Inc. (NASDAQ:HQY) Stock Holdings Lifted by Inspire Investing LLC

Inspire Investing LLC increased its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 75.2% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 24,027 shares of the company's stock after acquiring an additional 10,312 shares during the period. Inspire Investing LLC's holdings in HealthEquity were worth $1,967,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Atomi Financial Group Inc. purchased a new stake in HealthEquity during the 3rd quarter worth $208,000. GAMMA Investing LLC increased its position in shares of HealthEquity by 57.8% during the third quarter. GAMMA Investing LLC now owns 939 shares of the company's stock worth $77,000 after acquiring an additional 344 shares during the last quarter. Handelsbanken Fonder AB increased its position in shares of HealthEquity by 19.7% during the third quarter. Handelsbanken Fonder AB now owns 20,616 shares of the company's stock worth $1,687,000 after acquiring an additional 3,400 shares during the last quarter. SG Americas Securities LLC lifted its stake in shares of HealthEquity by 207.3% in the third quarter. SG Americas Securities LLC now owns 11,671 shares of the company's stock worth $955,000 after acquiring an additional 7,873 shares in the last quarter. Finally, Mattson Financial Services LLC purchased a new position in HealthEquity in the second quarter valued at about $477,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Vice Chairman Stephen Neeleman sold 35,000 shares of the stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $79.86, for a total value of $2,795,100.00. Following the completion of the transaction, the insider now owns 89,769 shares in the company, valued at $7,168,952.34. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other HealthEquity news, Vice Chairman Stephen Neeleman sold 35,000 shares of the company's stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total value of $2,795,100.00. Following the completion of the sale, the insider now directly owns 89,769 shares in the company, valued at $7,168,952.34. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now owns 54,719 shares in the company, valued at approximately $4,540,582.62. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 44,497 shares of company stock worth $3,579,769. 2.20% of the stock is owned by company insiders.

HealthEquity Stock Performance

NASDAQ:HQY traded down $0.45 during mid-day trading on Monday, hitting $84.97. The stock had a trading volume of 355,375 shares, compared to its average volume of 618,205. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The company has a 50 day simple moving average of $77.48 and a 200-day simple moving average of $79.31. The stock has a market capitalization of $7.39 billion, a price-to-earnings ratio of 92.36, a P/E/G ratio of 1.31 and a beta of 0.52. HealthEquity, Inc. has a 52 week low of $61.81 and a 52 week high of $88.26.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, beating analysts' consensus estimates of $0.50 by $0.16. The company had revenue of $299.93 million for the quarter, compared to analysts' expectations of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. On average, research analysts expect that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have issued reports on HQY. Bank of America dropped their price objective on HealthEquity from $105.00 to $100.00 and set a "buy" rating on the stock in a report on Wednesday, September 4th. Wells Fargo & Company increased their price target on shares of HealthEquity from $107.00 to $110.00 and gave the stock an "overweight" rating in a research report on Thursday, June 20th. JMP Securities reissued a "market outperform" rating and issued a $105.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $92.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. Finally, Barrington Research reiterated an "outperform" rating and issued a $105.00 price target on shares of HealthEquity in a report on Friday, September 20th. Twelve investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $103.83.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.